Hyperactive Delirium

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hyperactive Delirium trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT04824144

Effects of Dexmedetomidine in Patients With Agitated Delirium in Palliative Care

The goal of this multi-centre phase I/II open-label, single-arm study is to determine the feasibility, optimal dose, and preliminary efficacy of dexmedetomidine…

Canada50 participantsStarted 2024-01-30

Treatment: Dexmedetomidine Hydrochloride

All recent trials (14 shown)

Not Yet RecruitingPhase 3

NCT07548489

Phenobarbital for Agitated Delirium

The goal of this clinical trial is to test whether the medication phenobarbital is as effective for treating agitated delirium among adult patients admitted to…

United States150 participantsStarted 2026-06

Treatment: Phenobarbital, Conventional therapy group

Not Yet RecruitingPhase 4

NCT07377981

An Exploratory Study of the Efficacy and Safety of Esketamine and Dexmedetomidine in Non-Intubated ICU Patients With Hyp…

This investigator-initiated, randomized, controlled, superiority trial aims to assess the efficacy and safety of esketamine combined with dexmedetomidine for th…

China132 participantsStarted 2026-06-02

Treatment: Esketamine combined with dexmedetomidine, Dexmedetomidine

Hyperactive Delirium

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Effects of Dexmedetomidine in Patients With Agitated Delirium in Palliative Care

All recent trials (14 shown)

Phenobarbital for Agitated Delirium

An Exploratory Study of the Efficacy and Safety of Esketamine and Dexmedetomidine in Non-Intubated ICU Patients With Hyp…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Effects of Dexmedetomidine in Patients With Agitated Delirium in Palliative Care

All recent trials (14 shown)

Phenobarbital for Agitated Delirium

An Exploratory Study of the Efficacy and Safety of Esketamine and Dexmedetomidine in Non-Intubated ICU Patients With Hyp…

Intelligent Intensive Care Unit

HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Co…

Quetiapine Versus Haloperidol in the Management of Hyperactive Delirium

Influence of Dexmedetomidine or Propofol on ICU Delirium

Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium

Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU

A Pilot Study of "Stanford Proxy Test for Delirium" (S-PTD)

MindfulGarden in Treatment of Hyperactive Delirium in a Hospital Setting

Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)

Delirium Prevention in Patients From the Intensive Care Unit (DELA)

Subcutaneous Olanzapine for Hyperactive or Mixed Delirium